TCRX Stock Analysis: Buy, Sell, or Hold?
TCRX - TScan Therapeutics, Inc. Common Stock
$0.79
-0.01 (-0.70%)
âŧ
5d:
-3.76%
30d:
+3.31%
90d:
-25.82%
WAIT
LOW Confidence
Analysis Updated: Aug 25, 2026 12:00 AM ET
Earnings: Aug 11, 2026
0d
Get Alerted When TCRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: TCRX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: TCRX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: TCRX is currently trading at $0.79, which is considered fair relative to its 30-day fair value range of $0.74 to $0.84.
Technical Outlook: Technically, TCRX is in a strong downtrend. Immediate support is located at $0.74, while resistance sits at $0.84.
Market Sentiment: TCRX scores 62/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $6.00 (+656.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TCRX is in a strong downtrend. Immediate support is located at $0.74, while resistance sits at $0.84.
Market Sentiment: TCRX scores 62/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $6.00 (+656.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.74 -
$0.84
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (62/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 656.0% below Wall St target ($6.00)
- WARNING: Composite score 43/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.74 -
$0.84
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.74
Resistance Level
$0.84
Current Trend
Strong Downtrend
Technical data as of
Aug 25, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.85
Wall Street Target
$6.00
(+656.0%)
Revenue Growth (YoY)
-65.8%
Share & Embed Analysis
Last updated: August 26, 2026 9:40 AM ET
Data refreshes hourly during market hours. Next update: 10:40 AM
Data refreshes hourly during market hours. Next update: 10:40 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TCRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 63 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 54 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 53 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 38 SELL |
